Skip to main content

Table 2 Mortality, complications and co-treatments according to treatment group

From: Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial

 

iNO (n/N, %)

Placebo (n/N, %)

OR (95 % CI)

p value

Mortality

 Mortality, 48 h

6/87 (6.9 %)

8/92 (8.7 %)

0.78 (0.26–2.3)

0.65

 Mortality, in hospital

7/87 (8.0 %)

8/92 (8.7 %)

0.92 (0.32–2.7)

0.88

 Mortality, 14 days

7/87 (8.0 %)

9/91 (9.9 %)

0.80 (0.28–2.2)

0.67

 Death or sequelae at 14 days

12/87 (13 %)

16/91 (14 %)

0.75 (0.33–1.7)

0.75

 Mortality in strictly defined severe malariaa

7/81 (8.6 %)

9/88 (10 %)

0.83 (0.29–2.3)

0.73

 Mortality in strictly defined cerebral malariab

6/53 (11 %)

8/51 (16 %)

0.69 (0.22–2.1)

0.51

 Mortality in HIV

1/4 (25 %)

0/1 (0 %)

1.0

Complications

 Development of comac

2/26 (7·7 %)

0/34 (0 %)

0.18

 Deterioration of coma score

8/86 (9·3 %)

5/91 (5·5 %)

1·8 (0·55–5·6)

0.33

 Convulsions developing or persisting >6 h after admission

19/87 (22 %)

13/91 (14 %)

1.7 (0·77–3·6)

0.19

 Hypoglycaemia (<3 mmol/L)

10/88 (10 %)

17/91 (19 %)

0.56 (0·24–1·3)

0.12

 Severe anaemia (<50 g/L) after admissionc

11/35 (31 %)

5/34 (15 %)

2·7 (0.81–8.7)

0.10

 Haemoglobinuriac

0/68 (0 %)

3/76 (3.9 %)

0 (0–3.6)

0.25

Co-treatments

 Blood transfusion

65/87 (75 %)

67/91 (74 %)

1.1 (0.54–2.1)

1.0

 Intravenous fluids

80/88 (91 %)

82/91 (90 %)

1.1 (0.40–3.0)

1.0

 Antibiotics (any)

82/87 (94 %)

80/91 (88 %)

2.3 (0.75–6.8)

0.19

 Ceftriaxone

81/87 (93 %)

76/91 (84 %)

2.7 (0.98–7.2)

0.06

 Anticonvulsant (any)

51/87 (59 %)

36/91 (40 %)

2.2 (1.2–3.9)

0.016

 Diazepam

40/87 (46 %)

27/91 (30 %)

2.0 (1.1–3.7)

0.030

 Phenobarbitone

29/87 (33 %)

23/91 (25 %)

1.5 (0.77–2.8)

0.25

 Antipyretic (any)

64/87 (74 %)

71/91 (78 %)

0.78 (0.39–1.6)

0.60

  1. OR odds ratio
  2. aStrictly defined severe malaria as in AQUAMAT [25]. At least one of the following criteria was required: plasma base excess <–3.3 mmol/L; Blantyre coma scale <3/5; haemoglobin <50 g/L and parasitaemia >100,000 parasites/μL; compensated shock (capillary refill ≥3 s but no hypotension); decompensated shock (systolic blood pressure <70 mmHg and cool peripheries); asexual parasitaemia >10 %; visible jaundice and >100,000 parasites/μL; plasma glucose <3 mmol/L; respiratory distress (defined as costal indrawing, use of accessory muscles, nasal alar flaring, or deep breathing)
  3. bStrictly defined cerebral malaria required Blantyre coma scale <3, exclusion of hypoglycaemia and post-ictal state as the cause of coma
  4. cDevelopment of coma, anaemia and haemoglobinuria was assessed only in patients without these disorders on admission